- 21297 Foothill Blvd, Ste 203 Hayward, CA 94541 (by appointment only)
- (415) 636-9700
- hello@exxceedwellness.com
Short answer: A standard TMS course runs five days a week for about six weeks, roughly 30 to 36 sessions, followed by a taper. Most people who respond begin noticing change somewhere between week two and week four. Some improve earlier. Some do not show meaningful change until later in the course, which is why finishing the full course matters before judging whether it worked.
TMS is not a single procedure. It is a series of daily sessions.
Plan for a commitment of roughly two months from first session to completed taper.
There is no single day when TMS begins working, and clinicians cannot predict in advance which week a given patient will respond.
In a multisite study of 307 outpatients treated at 42 US clinical TMS practices, patients were assessed at baseline, at week two, at the point of maximal acute benefit, and again at week six when the course extended beyond six weeks. That week two assessment point reflects how the field thinks about the timeline: early enough that some change may be measurable, but too early to conclude anything final (Carpenter et al., Depression and Anxiety, 2012).
A common pattern is that other people notice first. Sleep, appetite, morning energy, and irritability often shift before mood itself feels different. Patients frequently report that a partner or coworker commented on a change before they registered it themselves.
Two terms get used, and they mean different things.
In that same multisite study of patients who had not improved adequately on antidepressant medication, clinician-assessed response was 58.0 percent and remission was 37.1 percent. Patient-reported response ranged from 41.5 to 56.4 percent and remission from 26.5 to 28.7 percent depending on the self-report scale used (Carpenter et al., 2012).
Those figures come from a population that had already failed an average of 2.5 adequate antidepressant trials in the current episode. They are not a promise of individual outcome.
Several factors influence how quickly change appears:
This is the most common question in the middle of a course, and the answer is usually to continue.
Late response is well recognized in TMS. A meaningful proportion of patients who show little at week three go on to respond by the end of the acute course. Stopping at week three converts an incomplete trial into an uninterpretable one.
That said, a lack of any movement partway through should prompt a review rather than passive continuation. A clinician may reassess the diagnosis, check for an untreated contributor such as a thyroid problem or sleep apnea, adjust the stimulation target or intensity, or reconsider concurrent medications.
A separate multisite study followed 257 patients for 52 weeks after they completed an acute TMS course. Improvement measured at the end of acute treatment was sustained across the follow-up period, and the proportion in remission at the end of follow-up remained similar to the proportion at the end of acute treatment.
Among 120 patients who met response or remission criteria at the end of acute treatment, 75 of them, or 62.5 percent, continued to meet response criteria throughout the year. Over the same period, 36.2 percent received some reintroduction of TMS, with a mean of 16.2 additional treatment days (Dunner et al., Journal of Clinical Psychiatry, 2014).
Two practical points follow from that. Benefit tends to hold for most responders over a year. And a meaningful minority need retreatment at some point, which is worth planning for financially and logistically before starting.
Most clinicians reassess formally around session ten to fifteen, and again at the end of the acute course. A full course of roughly 30 to 36 sessions is generally needed before concluding that TMS did not work.
Accelerated protocols deliver multiple sessions per day over a compressed schedule and are available at some centers. Whether an accelerated protocol is appropriate, and whether your insurance will authorize it, are separate questions to raise during evaluation.
Usually yes. TMS is most often delivered alongside continued medication rather than as a replacement. Any medication change should be made by your prescriber, not on your own.
Most patients continue with medication management and follow-up visits. Some need maintenance or repeat TMS later if symptoms return.
Occasional missed sessions are usually manageable and are made up at the end. Frequent gaps are more of a problem and should be discussed with your treatment team.
Whether TMS is a reasonable option depends on your diagnosis, how many medications you have tried, and what your insurance plan requires. You can read more about TMS therapy at Exxceed Wellness, review TMS cost in California, or check coverage under Medi-Cal and Medicare.
To find out whether you qualify, request a consultation and we will review your treatment history and verify your benefits before anything begins.
This article is for educational purposes and is not medical advice. It does not establish a clinician and patient relationship and it is not a substitute for individual evaluation. Response rates reported in research studies describe groups, not individuals, and no treatment outcome is guaranteed. Discuss risks, benefits, and alternatives with a qualified clinician who knows your history. If you are in crisis or thinking about harming yourself, call or text 988 in the United States.
In person in Hayward or by telehealth across California. We verify your insurance benefits before your first visit.
